How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?

Autores
Scioscia, Nathalia Paula; Pensel, Patricia Eugenia; Albani, Clara Maria; Fabbri, Julia; Denegri, Guillermo Maria; Elissondo, María Celina
Año de publicación
2021
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
Portal vein injection is a technique used for the development of different murine models of pathologies and parasitic diseases in the liver. These procedures require laparotomy and must be performed under anesthesia and analgesia to prevent discomfort, pain and /or distress. In order to optimize the survival rate of animals, the purpose of this study was to evaluate an injectable anesthesia protocol for the development of a murine model of hepatic cystic echinococcosis in female CF-1 mice. Animal procedures and management protocols were approved by the Institutional Animal Care and Use Committee of the Faculty of Exact and Natural Sciences, National University of Mar del Plata (RDs 468/17 and 211/2018). Forty three mice (Mus musculus; 6-7 weeks of age, body weight 26 ± 2 g) were allocated into six groups: 1) ketamine/xylazine 100/10 mg/kg; 2) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg; 3) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg + yohimbine; 4) ketamine/xylazine 80/8 mg/kg; 5) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg; and 6) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine. Atropine sulfate (0.4 mg/kg, subcutaneously) and tramadol hydrochloride [2 mg/kg, via intraperitoneal (IP)] were administered as pre-anesthetic drugs. The anesthetic cocktail (ketamine/xylazine) was applied IP and after confirming the loss of reflexes of mice, portal vein infection with Echinococcus granulosus protoscoleces was carried out. Yohimbine (a reverser of xylazine, 0.5 mg/kg) was injected IP immediately at the end of the suture. All groups achieve a deep surgical anesthetic plane and profound analgesia, except mice treated only with ketamine/xylazine at the doses of 80/8 mg/kg. Pre-anesthetic drugs application significantly reduced time induction of animals compared with those that received only the anesthetic cocktail (P < 0.05). The mice that underwent laparotomy and received yohimbine after surgery had a survival rate of 100 %. Moreover, treatment with yohimbine significantly reduced the recovery time of mice treated with pre-anesthetic drugs and ketamine/xylazine 80/8 mg/kg. In addition, we found differences between the response to the doses of ketamine/xylazine in animals treated with pre-anesthetic drugs and yohimbine. The recovery time of mice treated with ketamine/xylazine 80/8 mg/kg was significantly faster than that observed under doses of 100/10 mg/kg, respectively (P < 0.01). Therefore, the duration of action was significantly shorter when the applied doses of ketamine/xylazine were 80 and 8 mg/kg. We recommend the protocol that applied pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine as safe and reliable for the portal vein infection of mice with protoscoleces of E. granulosus.
Fil: Scioscia, Nathalia Paula. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Pensel, Patricia Eugenia. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Albani, Clara Maria. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Fabbri, Julia. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Denegri, Guillermo Maria. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Elissondo, María Celina. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
II Reunión Científica Internacional, VII Reunión Científica Regional y VI Congreso Nacional de Ciencia y Tecnología de Animales de Laboratorio
Argentina
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Materia
Echinococcus granulosus
Portal vein
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/156208

id CONICETDig_1343485282ed124e132bbbc61cc07532
oai_identifier_str oai:ri.conicet.gov.ar:11336/156208
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?Scioscia, Nathalia PaulaPensel, Patricia EugeniaAlbani, Clara MariaFabbri, JuliaDenegri, Guillermo MariaElissondo, María CelinaEchinococcus granulosusPortal veinhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Portal vein injection is a technique used for the development of different murine models of pathologies and parasitic diseases in the liver. These procedures require laparotomy and must be performed under anesthesia and analgesia to prevent discomfort, pain and /or distress. In order to optimize the survival rate of animals, the purpose of this study was to evaluate an injectable anesthesia protocol for the development of a murine model of hepatic cystic echinococcosis in female CF-1 mice. Animal procedures and management protocols were approved by the Institutional Animal Care and Use Committee of the Faculty of Exact and Natural Sciences, National University of Mar del Plata (RDs 468/17 and 211/2018). Forty three mice (Mus musculus; 6-7 weeks of age, body weight 26 ± 2 g) were allocated into six groups: 1) ketamine/xylazine 100/10 mg/kg; 2) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg; 3) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg + yohimbine; 4) ketamine/xylazine 80/8 mg/kg; 5) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg; and 6) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine. Atropine sulfate (0.4 mg/kg, subcutaneously) and tramadol hydrochloride [2 mg/kg, via intraperitoneal (IP)] were administered as pre-anesthetic drugs. The anesthetic cocktail (ketamine/xylazine) was applied IP and after confirming the loss of reflexes of mice, portal vein infection with Echinococcus granulosus protoscoleces was carried out. Yohimbine (a reverser of xylazine, 0.5 mg/kg) was injected IP immediately at the end of the suture. All groups achieve a deep surgical anesthetic plane and profound analgesia, except mice treated only with ketamine/xylazine at the doses of 80/8 mg/kg. Pre-anesthetic drugs application significantly reduced time induction of animals compared with those that received only the anesthetic cocktail (P < 0.05). The mice that underwent laparotomy and received yohimbine after surgery had a survival rate of 100 %. Moreover, treatment with yohimbine significantly reduced the recovery time of mice treated with pre-anesthetic drugs and ketamine/xylazine 80/8 mg/kg. In addition, we found differences between the response to the doses of ketamine/xylazine in animals treated with pre-anesthetic drugs and yohimbine. The recovery time of mice treated with ketamine/xylazine 80/8 mg/kg was significantly faster than that observed under doses of 100/10 mg/kg, respectively (P < 0.01). Therefore, the duration of action was significantly shorter when the applied doses of ketamine/xylazine were 80 and 8 mg/kg. We recommend the protocol that applied pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine as safe and reliable for the portal vein infection of mice with protoscoleces of E. granulosus.Fil: Scioscia, Nathalia Paula. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaFil: Pensel, Patricia Eugenia. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaFil: Albani, Clara Maria. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaFil: Fabbri, Julia. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaFil: Denegri, Guillermo Maria. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaFil: Elissondo, María Celina. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; ArgentinaII Reunión Científica Internacional, VII Reunión Científica Regional y VI Congreso Nacional de Ciencia y Tecnología de Animales de LaboratorioArgentinaAsociación Argentina de Ciencia y Tecnología de Animales de LaboratorioAsociación Argentina de Ciencia y Tecnología de Animales de Laboratorio2021info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónBookhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/156208How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?; II Reunión Científica Internacional, VII Reunión Científica Regional y VI Congreso Nacional de Ciencia y Tecnología de Animales de Laboratorio; Argentina; 2021; 66-67978-987-47524-0-6CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://aacytal.com.ar/wp-content/uploads/CongresoAACyTAL2021_Actas-del-Congreso.pdfInternacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:11:28Zoai:ri.conicet.gov.ar:11336/156208instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:11:29.05CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
title How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
spellingShingle How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
Scioscia, Nathalia Paula
Echinococcus granulosus
Portal vein
title_short How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
title_full How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
title_fullStr How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
title_full_unstemmed How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
title_sort How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?
dc.creator.none.fl_str_mv Scioscia, Nathalia Paula
Pensel, Patricia Eugenia
Albani, Clara Maria
Fabbri, Julia
Denegri, Guillermo Maria
Elissondo, María Celina
author Scioscia, Nathalia Paula
author_facet Scioscia, Nathalia Paula
Pensel, Patricia Eugenia
Albani, Clara Maria
Fabbri, Julia
Denegri, Guillermo Maria
Elissondo, María Celina
author_role author
author2 Pensel, Patricia Eugenia
Albani, Clara Maria
Fabbri, Julia
Denegri, Guillermo Maria
Elissondo, María Celina
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Echinococcus granulosus
Portal vein
topic Echinococcus granulosus
Portal vein
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Portal vein injection is a technique used for the development of different murine models of pathologies and parasitic diseases in the liver. These procedures require laparotomy and must be performed under anesthesia and analgesia to prevent discomfort, pain and /or distress. In order to optimize the survival rate of animals, the purpose of this study was to evaluate an injectable anesthesia protocol for the development of a murine model of hepatic cystic echinococcosis in female CF-1 mice. Animal procedures and management protocols were approved by the Institutional Animal Care and Use Committee of the Faculty of Exact and Natural Sciences, National University of Mar del Plata (RDs 468/17 and 211/2018). Forty three mice (Mus musculus; 6-7 weeks of age, body weight 26 ± 2 g) were allocated into six groups: 1) ketamine/xylazine 100/10 mg/kg; 2) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg; 3) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg + yohimbine; 4) ketamine/xylazine 80/8 mg/kg; 5) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg; and 6) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine. Atropine sulfate (0.4 mg/kg, subcutaneously) and tramadol hydrochloride [2 mg/kg, via intraperitoneal (IP)] were administered as pre-anesthetic drugs. The anesthetic cocktail (ketamine/xylazine) was applied IP and after confirming the loss of reflexes of mice, portal vein infection with Echinococcus granulosus protoscoleces was carried out. Yohimbine (a reverser of xylazine, 0.5 mg/kg) was injected IP immediately at the end of the suture. All groups achieve a deep surgical anesthetic plane and profound analgesia, except mice treated only with ketamine/xylazine at the doses of 80/8 mg/kg. Pre-anesthetic drugs application significantly reduced time induction of animals compared with those that received only the anesthetic cocktail (P < 0.05). The mice that underwent laparotomy and received yohimbine after surgery had a survival rate of 100 %. Moreover, treatment with yohimbine significantly reduced the recovery time of mice treated with pre-anesthetic drugs and ketamine/xylazine 80/8 mg/kg. In addition, we found differences between the response to the doses of ketamine/xylazine in animals treated with pre-anesthetic drugs and yohimbine. The recovery time of mice treated with ketamine/xylazine 80/8 mg/kg was significantly faster than that observed under doses of 100/10 mg/kg, respectively (P < 0.01). Therefore, the duration of action was significantly shorter when the applied doses of ketamine/xylazine were 80 and 8 mg/kg. We recommend the protocol that applied pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine as safe and reliable for the portal vein infection of mice with protoscoleces of E. granulosus.
Fil: Scioscia, Nathalia Paula. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Pensel, Patricia Eugenia. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Albani, Clara Maria. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Fabbri, Julia. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Denegri, Guillermo Maria. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
Fil: Elissondo, María Celina. Universidad Nacional de Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - Mar del Plata. Instituto de Investigaciones En Produccion, Sanidad y Ambiente.; Argentina
II Reunión Científica Internacional, VII Reunión Científica Regional y VI Congreso Nacional de Ciencia y Tecnología de Animales de Laboratorio
Argentina
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
description Portal vein injection is a technique used for the development of different murine models of pathologies and parasitic diseases in the liver. These procedures require laparotomy and must be performed under anesthesia and analgesia to prevent discomfort, pain and /or distress. In order to optimize the survival rate of animals, the purpose of this study was to evaluate an injectable anesthesia protocol for the development of a murine model of hepatic cystic echinococcosis in female CF-1 mice. Animal procedures and management protocols were approved by the Institutional Animal Care and Use Committee of the Faculty of Exact and Natural Sciences, National University of Mar del Plata (RDs 468/17 and 211/2018). Forty three mice (Mus musculus; 6-7 weeks of age, body weight 26 ± 2 g) were allocated into six groups: 1) ketamine/xylazine 100/10 mg/kg; 2) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg; 3) pre-anesthetic drugs + ketamine/xylazine 100/10 mg/kg + yohimbine; 4) ketamine/xylazine 80/8 mg/kg; 5) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg; and 6) pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine. Atropine sulfate (0.4 mg/kg, subcutaneously) and tramadol hydrochloride [2 mg/kg, via intraperitoneal (IP)] were administered as pre-anesthetic drugs. The anesthetic cocktail (ketamine/xylazine) was applied IP and after confirming the loss of reflexes of mice, portal vein infection with Echinococcus granulosus protoscoleces was carried out. Yohimbine (a reverser of xylazine, 0.5 mg/kg) was injected IP immediately at the end of the suture. All groups achieve a deep surgical anesthetic plane and profound analgesia, except mice treated only with ketamine/xylazine at the doses of 80/8 mg/kg. Pre-anesthetic drugs application significantly reduced time induction of animals compared with those that received only the anesthetic cocktail (P < 0.05). The mice that underwent laparotomy and received yohimbine after surgery had a survival rate of 100 %. Moreover, treatment with yohimbine significantly reduced the recovery time of mice treated with pre-anesthetic drugs and ketamine/xylazine 80/8 mg/kg. In addition, we found differences between the response to the doses of ketamine/xylazine in animals treated with pre-anesthetic drugs and yohimbine. The recovery time of mice treated with ketamine/xylazine 80/8 mg/kg was significantly faster than that observed under doses of 100/10 mg/kg, respectively (P < 0.01). Therefore, the duration of action was significantly shorter when the applied doses of ketamine/xylazine were 80 and 8 mg/kg. We recommend the protocol that applied pre-anesthetic drugs + ketamine/xylazine 80/8 mg/kg + yohimbine as safe and reliable for the portal vein infection of mice with protoscoleces of E. granulosus.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Book
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/156208
How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?; II Reunión Científica Internacional, VII Reunión Científica Regional y VI Congreso Nacional de Ciencia y Tecnología de Animales de Laboratorio; Argentina; 2021; 66-67
978-987-47524-0-6
CONICET Digital
CONICET
url http://hdl.handle.net/11336/156208
identifier_str_mv How to improve the survival of female cf-1 mice during the infection via the portal vein with Echinococcus granulosus protoscoleces?; II Reunión Científica Internacional, VII Reunión Científica Regional y VI Congreso Nacional de Ciencia y Tecnología de Animales de Laboratorio; Argentina; 2021; 66-67
978-987-47524-0-6
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://aacytal.com.ar/wp-content/uploads/CongresoAACyTAL2021_Actas-del-Congreso.pdf
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Internacional
dc.publisher.none.fl_str_mv Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
publisher.none.fl_str_mv Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846083263109529600
score 13.22299